HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Jan 13, 2024 | Option Exercise | $2.15 | 756 | 1,625 | 55,907 | Jan 16, 2024, 05:19 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Officer | Nov 17, 2023 | Buy | $1.09 | 25,000 | 27,250 | 79,000 | Nov 21, 2023, 12:19 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Officer | Nov 16, 2023 | Buy | $0.94 | 50,000 | 46,995 | 54,000 | Nov 20, 2023, 10:07 AM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | Chief Executive Officer | Nov 16, 2023 | Buy | $0.92 | 150,000 | 137,970 | 186,496 | Nov 17, 2023, 12:37 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, Chief Financial Officer | Nov 16, 2023 | Buy | $0.89 | 85,000 | 75,599 | 85,000 | Nov 17, 2023, 12:36 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Jul 25, 2023 | Option Exercise | $1.51 | 14,743 | 22,262 | 53,198 | Oct 17, 2023, 07:57 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Oct 13, 2023 | Option Exercise | $0.72 | 860 | 619 | 54,822 | Oct 17, 2023, 07:57 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | Chief Executive Officer | Aug 22, 2023 | Option Exercise | $1.65 | 692 | 1,142 | 36,496 | Aug 24, 2023, 04:09 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam | Director | Jul 21, 2023 | Buy | $1.37 | 2,486,744 | 3,406,839 | 6,986,744 | Jul 25, 2023, 04:22 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Jul 13, 2023 | Option Exercise | $1.31 | 2,012 | 2,636 | 33,754 | Jul 17, 2023, 05:51 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Jul 13, 2023 | Option Exercise | $1.31 | 860 | 1,127 | 25,310 | Jul 17, 2023, 05:51 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | Chief Executive Officer | May 22, 2023 | Option Exercise | $1.45 | 691 | 1,002 | 37,188 | May 24, 2023, 05:04 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Apr 13, 2023 | Option Exercise | $2.88 | 2,012 | 5,795 | 29,952 | Apr 17, 2023, 05:28 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Apr 13, 2023 | Option Exercise | $2.88 | 2,012 | 5,795 | 46,648 | Apr 17, 2023, 05:27 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Apr 13, 2023 | Option Exercise | $2.88 | 860 | 2,477 | 23,685 | Apr 17, 2023, 05:27 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Apr 13, 2023 | Option Exercise | $2.88 | 1,417 | 4,081 | 28,330 | Apr 17, 2023, 05:26 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Jan 13, 2023 | Option Exercise | $3.17 | 2,012 | 6,378 | 26,150 | Jan 17, 2023, 05:37 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Oct 31, 2022 | Option Exercise | $3.27 | 1,654 | 5,413 | 22,348 | Jan 17, 2023, 05:37 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Oct 31, 2022 | Option Exercise | $3.27 | 1,655 | 5,416 | 163,441 | Jan 17, 2023, 05:36 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Jan 13, 2023 | Option Exercise | $3.17 | 5,219 | 16,544 | 177,989 | Jan 17, 2023, 05:36 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Jan 13, 2023 | Option Exercise | $3.17 | 2,012 | 6,378 | 42,846 | Jan 17, 2023, 05:36 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Jan 13, 2023 | Option Exercise | $3.17 | 1,013 | 3,211 | 22,061 | Jan 17, 2023, 05:35 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Oct 31, 2022 | Option Exercise | $3.27 | 1,655 | 5,416 | 20,131 | Jan 17, 2023, 05:34 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Jan 13, 2023 | Option Exercise | $3.17 | 2,012 | 6,378 | 23,933 | Jan 17, 2023, 05:34 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Oct 13, 2022 | Option Exercise | $3.76 | 2,012 | 7,565 | 20,694 | Oct 17, 2022, 04:38 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Oct 13, 2022 | Option Exercise | $3.76 | 5,219 | 19,623 | 161,786 | Oct 17, 2022, 04:38 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Oct 13, 2022 | Option Exercise | $3.76 | 2,012 | 7,565 | 39,044 | Oct 17, 2022, 04:37 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Oct 13, 2022 | Option Exercise | $3.76 | 861 | 3,237 | 20,589 | Oct 17, 2022, 04:36 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Oct 13, 2022 | Option Exercise | $3.76 | 2,012 | 7,565 | 18,476 | Oct 17, 2022, 04:36 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Apr 29, 2022 | Option Exercise | $3.84 | 1,505 | 5,782 | 13,090 | Jul 15, 2022, 04:58 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Jul 13, 2022 | Option Exercise | $3.01 | 2,012 | 6,056 | 16,892 | Jul 15, 2022, 04:58 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Apr 29, 2022 | Option Exercise | $3.84 | 1,504 | 5,778 | 132,688 | Jul 15, 2022, 04:57 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Jul 13, 2022 | Option Exercise | $3.01 | 5,219 | 15,709 | 147,237 | Jul 15, 2022, 04:57 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Jul 13, 2022 | Option Exercise | $3.01 | 2,012 | 6,056 | 35,242 | Jul 15, 2022, 04:56 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Jul 13, 2022 | Option Exercise | $3.01 | 860 | 2,589 | 18,965 | Jul 15, 2022, 04:55 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Jul 13, 2022 | Option Exercise | $3.01 | 2,012 | 6,056 | 14,674 | Jul 15, 2022, 04:55 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Apr 29, 2022 | Option Exercise | $3.84 | 1,504 | 5,778 | 12,376 | May 04, 2022, 07:01 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | May 03, 2022 | Sale | $4.76 | 1,504 | 7,154 | 10,872 | May 04, 2022, 07:01 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Apr 13, 2022 | Option Exercise | $6.07 | 2,012 | 12,213 | 11,585 | Apr 15, 2022, 05:06 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Apr 13, 2022 | Option Exercise | $6.07 | 5,219 | 31,679 | 131,184 | Apr 15, 2022, 05:05 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Apr 13, 2022 | Option Exercise | $6.07 | 2,012 | 12,213 | 31,440 | Apr 15, 2022, 05:04 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Apr 13, 2022 | Option Exercise | $6.07 | 860 | 5,220 | 17,340 | Apr 15, 2022, 05:03 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Apr 13, 2022 | Option Exercise | $6.07 | 2,012 | 12,213 | 10,872 | Apr 15, 2022, 05:03 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Jan 13, 2022 | Option Exercise | $8.30 | 2,012 | 16,700 | 7,783 | Jan 14, 2022, 05:09 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Jan 13, 2022 | Option Exercise | $8.30 | 5,219 | 43,318 | 116,635 | Jan 14, 2022, 05:08 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Jan 13, 2022 | Option Exercise | $8.30 | 2,012 | 16,700 | 27,638 | Jan 14, 2022, 05:07 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Jan 13, 2022 | Option Exercise | $8.30 | 966 | 8,018 | 15,716 | Jan 14, 2022, 05:06 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Jan 13, 2022 | Option Exercise | $8.30 | 2,012 | 16,700 | 7,070 | Jan 14, 2022, 05:05 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Oct 29, 2021 | Option Exercise | $9.36 | 817 | 7,646 | 23,836 | Dec 23, 2021, 06:59 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Christian Waage | Director | Dec 21, 2021 | Sale | $9.73 | 300 | 2,920 | 3,200 | Dec 23, 2021, 06:58 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Director | Dec 21, 2021 | Sale | $9.73 | 250 | 2,432 | 2,840 | Dec 23, 2021, 06:57 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Oct 13, 2021 | Option Exercise | $10.55 | 433 | 4,568 | 3,981 | Oct 15, 2021, 04:26 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Oct 13, 2021 | Option Exercise | $10.55 | 963 | 10,160 | 102,086 | Oct 15, 2021, 04:25 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Oct 13, 2021 | Option Exercise | $10.55 | 433 | 4,568 | 23,019 | Oct 15, 2021, 04:24 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Oct 13, 2021 | Option Exercise | $10.55 | 191 | 2,015 | 14,197 | Oct 15, 2021, 04:23 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Oct 13, 2021 | Option Exercise | $10.55 | 433 | 4,568 | 3,268 | Oct 15, 2021, 04:22 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Christian Waage | Director | Sep 21, 2021 | Sale | $12.31 | 300 | 3,692 | 3,500 | Sep 23, 2021, 04:30 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Director | Sep 21, 2021 | Sale | $12.30 | 250 | 3,074 | 3,090 | Sep 23, 2021, 04:29 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Apr 30, 2021 | Option Exercise | $13.90 | 1,530 | 21,263 | 2,347 | Jul 15, 2021, 04:52 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Jul 13, 2021 | Option Exercise | $13.48 | 433 | 5,837 | 3,164 | Jul 15, 2021, 04:52 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Jul 13, 2021 | Option Exercise | $13.48 | 963 | 12,981 | 99,403 | Jul 15, 2021, 04:50 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Apr 30, 2021 | Option Exercise | $13.90 | 1,529 | 21,249 | 96,721 | Jul 15, 2021, 04:50 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Apr 30, 2021 | Option Exercise | $13.90 | 971 | 13,494 | 21,385 | Jul 15, 2021, 04:49 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Jul 13, 2021 | Option Exercise | $13.48 | 433 | 5,837 | 22,202 | Jul 15, 2021, 04:49 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Apr 30, 2021 | Option Exercise | $13.90 | 1,530 | 21,263 | 13,475 | Jul 15, 2021, 04:48 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Jul 13, 2021 | Option Exercise | $13.48 | 191 | 2,575 | 13,836 | Jul 15, 2021, 04:48 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Jul 13, 2021 | Option Exercise | $13.48 | 433 | 5,837 | 2,451 | Jul 15, 2021, 04:47 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Director | Jun 21, 2021 | Sale | $15.20 | 250 | 3,801 | 3,340 | Jun 22, 2021, 05:05 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Christian Waage | Director | Apr 15, 2021 | Sale | $17.51 | 300 | 5,254 | 4,100 | Apr 16, 2021, 08:59 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Apr 13, 2021 | Option Exercise | $16.66 | 433 | 7,214 | 817 | Apr 15, 2021, 04:55 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Apr 13, 2021 | Option Exercise | $16.66 | 963 | 16,044 | 95,192 | Apr 15, 2021, 04:54 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Apr 13, 2021 | Option Exercise | $16.66 | 433 | 7,214 | 20,414 | Apr 15, 2021, 04:53 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Apr 13, 2021 | Option Exercise | $16.66 | 191 | 3,182 | 11,945 | Apr 15, 2021, 04:52 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Apr 13, 2021 | Option Exercise | $16.66 | 433 | 7,214 | 1,634 | Apr 15, 2021, 04:51 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Johnson Craig A | Director | Apr 06, 2021 | Sale | $17.22 | 250 | 4,305 | 3,590 | Apr 07, 2021, 05:04 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Jan 13, 2021 | Option Exercise | $18.16 | 423 | 7,682 | 827 | Jan 15, 2021, 04:30 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Jan 14, 2021 | Sale | $18.09 | 827 | 14,960 | 0 | Jan 15, 2021, 04:30 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Jan 13, 2021 | Option Exercise | $18.16 | 963 | 17,488 | 91,909 | Jan 15, 2021, 04:29 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Jan 13, 2021 | Option Exercise | $18.16 | 433 | 7,863 | 19,597 | Jan 15, 2021, 04:27 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, Chief Accounting Officer | Jan 13, 2021 | Option Exercise | $18.16 | 227 | 4,122 | 11,584 | Jan 15, 2021, 04:26 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Jan 13, 2021 | Option Exercise | $18.16 | 433 | 7,863 | 817 | Jan 15, 2021, 04:25 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Szekeres David Leslie | EVP, Chief Operating Officer | Jan 08, 2021 | Sale | $19.66 | 3,571 | 70,219 | 0 | Jan 08, 2021, 06:07 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | President & CCO | Oct 30, 2020 | Option Exercise | $11.65 | 637 | 7,423 | 18,780 | Dec 23, 2020, 04:24 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | EVP, Drug Development | Dec 22, 2020 | Option Exercise | $16.50 | 20,000 | 330,000 | 10,000 | Dec 23, 2020, 04:23 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Apr 30, 2020 | Option Exercise | $12.12 | 1,158 | 14,036 | 89,226 | Oct 15, 2020, 04:23 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | Executive VP, Drug Development | Apr 30, 2020 | Option Exercise | $12.12 | 1,158 | 14,036 | 1,158 | May 01, 2020, 06:48 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | Executive VP, Drug Development | May 01, 2020 | Sale | $13.97 | 1,158 | 16,176 | 0 | May 01, 2020, 06:48 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | Executive VP, Drug Development | Nov 29, 2019 | Sale | $19.50 | 48,000 | 936,000 | 24,000 | Dec 03, 2019, 06:30 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | TANG KEVIN C | Director | Oct 04, 2019 | Buy | $17.50 | 285,714 | 4,999,995 | 5,799,810 | Oct 07, 2019, 05:18 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Apr 30, 2019 | Option Exercise | $18.43 | 806 | 14,853 | 90,081 | Oct 04, 2019, 07:58 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Oct 03, 2019 | Buy | $17.50 | 4,571 | 79,993 | 94,652 | Oct 04, 2019, 07:58 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | EVP, Chief Commercial Officer | Oct 03, 2019 | Buy | $17.50 | 5,143 | 90,003 | 18,143 | Oct 04, 2019, 07:56 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Director | May 22, 2019 | Buy | $17.55 | 3,000 | 52,650 | 13,000 | May 23, 2019, 08:39 AM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Christian Waage | Director | May 15, 2019 | Buy | $18.04 | 1,400 | 25,262 | 1,400 | May 16, 2019, 08:44 AM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | Executive VP, Drug Development | Apr 30, 2019 | Option Exercise | $18.43 | 1,109 | 20,437 | 1,109 | May 02, 2019, 08:40 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | Executive VP, Drug Development | May 01, 2019 | Sale | $18.86 | 1,109 | 20,918 | 0 | May 02, 2019, 08:40 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | Executive VP, Drug Development | Oct 31, 2018 | Option Exercise | $23.60 | 494 | 11,656 | 494 | Nov 02, 2018, 09:17 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | Executive VP, Drug Development | Nov 02, 2018 | Sale | $30.62 | 494 | 15,125 | 0 | Nov 02, 2018, 09:17 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | MANHARD KIMBERLY | Executive VP, Drug Development | Oct 01, 2018 | Option Exercise | $22.54 | 12,000 | 270,433 | 6,000 | Oct 02, 2018, 09:12 PM |
HRTX | | HERON THERAPEUTICS, INC. /DE/ | Quart Barry D | Chief Executive Officer | Sep 14, 2018 | Option Exercise | $7.20 | 19,675 | 141,660 | 89,275 | Sep 14, 2018, 11:41 AM |